Register for December 13, 2018 Webinar


Science & Innovation Theater Webinar 


Recognizing the Potential of Precision Medicine in TRK Fusion Cancers
Sponsored by Bayer HealthCare and Loxo Oncology

Thursday, December 13, 2018, 2-3pm EST

The focus of this webinar is education on the potential of precision medicine in oncology with a focus on TRK Fusion Cancers and implications to the key stakeholders across the healthcare system. This will be followed by a high level question and answer session with representatives from both Bayer and Loxo Oncology.

During the course of the presentation, the presenters will:

  • Provide awareness on the concept of precision medicine in TRK Fusion Cancers
  • Educate on precision medicine’s potential to move the care of patients forward
  • Discuss considerations that payers and other stakeholders may encounter as advances in precision medicine shift the cancer treatment paradigm - which has long been based on tumor type - toward a biomarker-driven, tumor-agnostic approach


  • Anthony N. Sireci, MD, MSc
    Medical Director, Loxo Oncology, Inc.
  • Sibyl Anderson, MD
    Director US Medical Science/Oncology, Bayer HealthCare Pharmaceuticals

This webinar is sponsored, developed and presented by the sponsor.  The content of the Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy. 

Sponsored by:  

   Bayer&Loxo Logo 

** IMPORTANT: AMCP webinars are limited to the first 500 that join the webinar. However, AMCP will provide a link to the recording and slides to all registrants within a week from the webinar date. The recording and slides of sponsored webinars will be provided if permitted by the sponsor. 

For individuals from the media/press who are interested in attending, please contact Neal Learner at for more information.